Hydreight Technologies Inc (TSE:NURS) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Hydreight Technologies Inc. reported a record-breaking revenue for the fiscal year 2023, with adjusted revenue soaring by 102% from the previous year and GAAP revenue up by 170%. The company’s expansion efforts have successfully scaled up services to over 700 cities nationwide and grown its medical platform, as evidenced by onboarding 2,249 nurses and being recognized as one of Canada’s Companies to Watch. Amidst this growth, Hydreight has maintained a stable gross margin and continues to enhance its product offerings, including the addition of Semaglutide in December 2023.
For further insights into TSE:NURS stock, check out TipRanks’ Stock Analysis page.